|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date26 Apr 1996 |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date01 Mar 1956 |
|
|
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.US |
First Approval Date25 Jun 1980 |
100 Clinical Results associated with Parke Davis Pharmaceutical Research Div Warner Lambert Co
0 Patents (Medical) associated with Parke Davis Pharmaceutical Research Div Warner Lambert Co
100 Deals associated with Parke Davis Pharmaceutical Research Div Warner Lambert Co
100 Translational Medicine associated with Parke Davis Pharmaceutical Research Div Warner Lambert Co